Related Experiment Video

Updated: Jul 10, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Targeting platelets for prevention and treatment of cardiovascular disease

Todd A Duhamel1, Yan-Jun Xu, Amarjit S Arneja

  • 1University of Manitoba, Institute of Cardiovascular Sciences, St Boniface General Hospital Research Center, Department of Physiology, Faculty of Medicine, 351 Tache Avenue, Winnipeg, Manitoba, R2H 2A6, Canada.

Expert Opinion on Therapeutic Targets
|November 21, 2007
PubMed

Insights

Emerging treatments for cardiovascular disease focus on novel pharmacologic agents and natural compounds that modulate platelet function. These interventions offer broader applications beyond traditional anti-platelet drugs, potentially impacting atherosclerosis and thrombosis.

Area of Science:

  • Cardiovascular Science
  • Pharmacology
  • Nutritional Science

Background:

  • Platelets are crucial in cardiovascular diseases like thrombosis, atherosclerosis, hypertension, heart attack, and stroke.
  • Classical anti-platelet agents effectively treat specific conditions but have limitations due to direct platelet function targeting.
  • Novel anti-platelet agents and natural compounds offer broader therapeutic potential by influencing platelet and smooth muscle cell functions.

Purpose of the Study:

  • To review emerging pharmacologic, nutritional, and nutraceutical interventions for cardiovascular disease.
  • To highlight agents that influence platelet function for cardiovascular disease prevention and treatment.
  • To explore the potential of novel therapies beyond traditional anti-platelet drugs.

Main Methods:

  • Literature review of pharmacologic interventions targeting platelet function.
  • Analysis of emerging anti-platelet agents affecting cardiac and vascular smooth muscle cells.
  • Exploration of natural food products and nutraceuticals impacting platelet activity and cardiovascular health.

Main Results:

  • Classical anti-platelet agents have proven benefits but also limitations.
  • Newly developed agents demonstrate broader applications by affecting both platelet and smooth muscle cell functions.
  • Natural products and nutraceuticals show potential in modifying cardiovascular abnormalities via platelet function, though mechanisms require further investigation.

Conclusions:

  • Emerging pharmacologic agents offer expanded therapeutic strategies for cardiovascular diseases.
  • Nutritional and nutraceutical interventions present promising avenues for cardiovascular disease management by modulating platelet function.
  • Further research is needed to elucidate the precise mechanisms of natural compounds in cardiovascular health.

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...